Log in

Relevant bibliographies by topics / Hepatitis B-positive / Journal articles

To see the other types of publications on this topic, follow the link: Hepatitis B-positive.

Journal articles on the topic 'Hepatitis B-positive'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hepatitis B-positive.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Full text

Abstract:

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

APA, Harvard, Vancouver, ISO, and other styles

2

O.W, Onwurah, Ajuba C.I, Nwoke C.G, and Anokwute M.U. "Prevalence of Hepatitis B e-Antigen among Hepatitis B positive subjects in Nnamdi Azikiwe University Teaching Hospital Nnewi." Journal of Clinical and Laboratory Research 3, no. 1 (2021): 01–04. http://dx.doi.org/10.31579/2768-0487/020.

Full text

Abstract:

Hepatitis B virus (HBV) is a common cause of liver disease throughout the world. Cirrhosis, liver failure and hepatocellular carcinoma develop in 15–40% of chronically infected hepatitis B virus individuals. HBV is transmitted through blood and other body fluids, including semen and saliva. The aim of this study was to determine the prevalence of HBeAg amongst HBsAg positive subjects in Nnamdi Azikiwe University Teaching Hospital, Nnewi (NAUTH) . This study was a cross sectional study and data were collected through oral interview and questionnaire. Five milliliters of blood was collected asep

APA, Harvard, Vancouver, ISO, and other styles

3

Han, Zhenge, Yong Liu, Jinshun Pan, Yongchun Bi, Jingli Liu, and Yi-Hua Zhou. "Occult hepatitis B virus infection with positive hepatitis B e antigen." Clinica Chimica Acta 438 (January 2015): 266–68. http://dx.doi.org/10.1016/j.cca.2014.09.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Fitria, Liza, Hartono Gunardi, and Arwin A. P. Akib. "Influence of Hepatitis B immunization to prevent vertical transmission of Hep-B virus in infants bam from Hep-B positive mother." Paediatrica Indonesiana 50, no. 6 (2016): 321. http://dx.doi.org/10.14238/pi50.6.2010.321-5.

Full text

Abstract:

Background Hepatitis B is one of the most common infectious diseases worldv.ide. Indonesia has moderate-high endemicity for hepatitis B infection. Perinatal transmission increases the risk for chronic hepatitis B. Infants from HBsAg-positive mothers should receive hepatitis B immunoglobulin (HBIG) and vaccination within 12 hours of birth, but this practice is not routinely done in Indonesia due to financial constraints.Objectives To detennine the influence of Hep-B immunization on preventing Hepatitis B vertical transmission. Methods A descriptive cohort study was conducted from May 2009 - Jan

APA, Harvard, Vancouver, ISO, and other styles

5

Waterson, A. P., June D. Almeida, Patricia M. Weeple, D. F. Hawkins, and Mary Cummins. "HEPATITIS B ANTIGEN-POSITIVE OBSTETRIC PATIENTS." BJOG: An International Journal of Obstetrics & Gynaecology 84, no. 9 (2008): 674–78. http://dx.doi.org/10.1111/j.1471-0528.1977.tb12679.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Beavers, Kimberly L. "TREATING HBeAg-POSITIVE CHRONIC HEPATITIS B." Evidence-Based Gastroenterology 4, no. 3 (2003): 114–15. http://dx.doi.org/10.1097/00132579-200308000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Shah, Niraj J., Elizabeth Paine, and Mary Burton. "3191 Two Cases of False Positive Hepatitis B Surface Antigen With Positive Hepatitis B E-Antigen." American Journal of Gastroenterology 114, no. 1 (2019): S1705. http://dx.doi.org/10.14309/01.ajg.0000602296.01002.64.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Schwarzwald, Heidi, and Nancy E. Kline. "False positive hepatitis B surface antigen test caused by hepatitis B vaccine." Pediatric Infectious Disease Journal 20, no. 11 (2001): 1101–2. http://dx.doi.org/10.1097/00006454-200111000-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Feld, Jordan, and E. Heathcote. "Hepatitis B e Antigen-Positive Chronic Hepatitis B: Natural History and Treatment." Seminars in Liver Disease 26, no. 2 (2006): 116–29. http://dx.doi.org/10.1055/s-2006-939750.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Liaw, Yun-Fan, Sien-Sing Yang, Tong-Jong Chen, and Chia-Ming Chu. "Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis." Journal of Hepatology 1, no. 3 (1985): 227–33. http://dx.doi.org/10.1016/s0168-8278(85)80050-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Scuderi, V., A. Ceriello, W. Santaniello, et al. "Hepatitis B Prophylaxis in Hepatitis B–Negative Recipients Transplanted With Donor Grafts Positive for Hepatitis B Core Antibodies." Transplantation Proceedings 43, no. 1 (2011): 271–73. http://dx.doi.org/10.1016/j.transproceed.2010.09.100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Seto, Wai-Kay, Danny Ka-Ho Wong, James Fung, et al. "High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B." PLoS ONE 7, no. 8 (2012): e43087. http://dx.doi.org/10.1371/journal.pone.0043087.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

QUDDUSI, H., S. ANWAR, and M. S. AKHTER. "Pregnancy Outcome in Hepatitis B and C Positive Mothers." Annals of King Edward Medical University 11, no. 2 (2021): 134–36. https://doi.org/10.21649/akemu.v11i2.4281.

Full text

Abstract:

Aims: To see frequency of hepatitis B and C in pregnant patient and the pregnancy outcome in hepatitis B and C positive mothers. Study design: descriptive study. Setting: This study was conducted in Gynae unit III and labour ward Nisbter hospital Multan from Jan 04 to Mar 05 in collaboration with Central Laboratory in our hospital. Material and methods: All pregnant patients admitted through OPD and labour ward who were found hepatitis B and C positive during screening were included in this study. Patient with chronic liver disease, cirrhosis and acute hepatitis due to A and E virus were exclu

APA, Harvard, Vancouver, ISO, and other styles

14

Shrivastava, Shikha, Nirupama TrehanPati, Shyam Kottilil, and Shiv Kumar Sarin. "Decline in Immature Transitional B Cells After Hepatitis B Vaccination in Hepatitis B Positive Newborns." Pediatric Infectious Disease Journal 32, no. 7 (2013): 792–94. http://dx.doi.org/10.1097/inf.0b013e31828df344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Anjum, Muhammad Usman, Muhammad Safdar Khan, Nazar Muhamamd Afridi, and Syed Humayun Shah. "HEPATITIS B AND C VIRUS INFECTIONS." Professional Medical Journal 22, no. 10 (2015): 1284–88. http://dx.doi.org/10.29309/tpmj/2015.22.10.981.

Full text

Abstract:

Patients with end stage renal disease require haemodialysis as a part of theirtreatment. The incidence of hepatitis B and C virus infection is quite high in patients undergoingmaintenance haemodialysis than in general population. This risk is specifically associatedwith use of blood and its products as well as repeated intravascular access in these patients.Objectives: To determine the seropositivity of hepatitis B and C virus infection in patientsreceiving haemodialysis. Design: Descriptive cross sectional study. Setting: NephrologyDepartment, Ayub Teaching Hospital, Abbottabad, Pakistan. Per

APA, Harvard, Vancouver, ISO, and other styles

16

Jyoti, Ranjan Behera, Ranjan Mallick Manas, Kumar Jena Sanjaya, Ranjan Barik Rashmi, Roy Debashisha, and Kumar Mohanty Anil. "Efficacy of Hepatitis B Immunoglobulin and Hepatitis B Vaccine in Prevention of Perinatal Transmission of Hepatitis B." International Journal of Pharmaceutical and Clinical Research 15, no. 11 (2023): 232–38. https://doi.org/10.5281/zenodo.11214130.

Full text

Abstract:

<strong>Introduction: </strong>Hepatitis B is a major global health problem and is a most serious type of viral hepatitis, which puts the people at high risk of death from cirrhosis of the liver and liver cancer. Approximately 30% of the world’s population, or about 2 billion persons, have serological evidence of either current or past infection with hepatitis B virus. Most people in China and India become infected with HBV during childhood. India has intermediate endemicity of Hepatitis B, with Hepatitis B surface antigen (HBsAg) prevalence between 2% and 7% among populations studi

APA, Harvard, Vancouver, ISO, and other styles

17

Lobello, S., U. Lorenzoni, A. Vian, A. Floreani, M. R. Brunetto, and M. Chiaramonte. "Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring." Journal of Viral Hepatitis 5, no. 1 (1998): 61–66. http://dx.doi.org/10.1046/j.1365-2893.1998.00083.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Lin, W. T., Y. M. Chen, D. Y. Chen, et al. "Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study." Lupus 27, no. 1 (2017): 66–75. http://dx.doi.org/10.1177/0961203317711009.

Full text

Abstract:

Objective We aimed to investigate risk of hepatitis B virus reactivation in systemic lupus erythematosus patients with different hepatitis B virus infection statuses receiving immunosuppressive therapy. Methods We retrospectively analyzed systemic lupus erythematosus patients with positive hepatitis B surface antigen or anti-hepatitis B core IgG antibody who underwent immunosuppressive therapies from January 2001 to December 2012 at a medical center in Taiwan for evidence of hepatitis B virus reactivation. Results During this period, 906 out of 3125 patients who were diagnosed with systemic lu

APA, Harvard, Vancouver, ISO, and other styles

19

Franchello, Alessandro, Valeria Ghisetti, Alfredo Marzano, Renato Romagnoli, and Mauro Salizzoni. "Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection." Liver Transplantation 11, no. 8 (2005): 922–28. http://dx.doi.org/10.1002/lt.20471.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Thornton, Alicia C., Sophie Jose, Sanjay Bhagani, et al. "Hepatitis B, hepatitis C, and mortality among HIV-positive individuals." AIDS 31, no. 18 (2017): 2525–32. http://dx.doi.org/10.1097/qad.0000000000001646.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Kim, Kyeongdeok, Manuel Lim, Jieun Kwon, et al. "HEPATITIS B IMMUNOGLOBULIN PROPHYLAXIS FOR PREVENTION OF DE NOVO HEPATITIS B INFECTION FROM HEPATITIS B CORE ANTIBODY-POSITIVE DONORS." Transplantation 104, S3 (2020): S527. http://dx.doi.org/10.1097/01.tp.0000701348.41608.48.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Kim, Kyeongdeok, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, and Jae-Won Joh. "Hepatitis B immunoglobulin prophylaxis for prevention of de novo Hepatitis B infection from hepatitis B core antibody-positive donors." Journal of Hepatology 73 (August 2020): S266—S267. http://dx.doi.org/10.1016/s0168-8278(20)31036-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Nguyen, Mindie H., and Emmet B. Keeffe. "Editorial Commentary:Are Hepatitis B e Antigen (HBeAg)–Positive Chronic Hepatitis B and HBeAg‐Negative Chronic Hepatitis B Distinct Diseases?" Clinical Infectious Diseases 47, no. 10 (2008): 1312–14. http://dx.doi.org/10.1086/592571.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pilmore, Helen L., and Edward J. Gane. "Hepatitis B–Positive Donors in Renal Transplantation." Transplantation Journal 94, no. 3 (2012): 205–10. http://dx.doi.org/10.1097/tp.0b013e31824e3db4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Rosen, Les B., Arkadi M. Rywlin, and Lionel Resnick. "Hepatitis B surface antigen positive skin lesions." American Journal of Dermatopathology 7, no. 6 (1985): 507–14. http://dx.doi.org/10.1097/00000372-198512000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Veroux, M., C. Puliatti, M. Macarone, et al. "Kidney Transplantation From Hepatitis B Surface Antigen–Positive Donors Into Hepatitis B Surface Antigen–Positive Recipients: Preliminary Findings." Transplantation Proceedings 37, no. 6 (2005): 2467–68. http://dx.doi.org/10.1016/j.transproceed.2005.06.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Veroux, M., C. Puliatti, M. Gagliano, et al. "Use of Hepatitis B Core Antibody-Positive Donor Kidneys in Hepatitis B Surface Antibody-Positive and -Negative Recipients." Transplantation Proceedings 37, no. 6 (2005): 2574–75. http://dx.doi.org/10.1016/j.transproceed.2005.06.068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Fan, Rong, Jie Peng, Qing Xie, et al. "Combining Hepatitis B Virus RNA and Hepatitis B Core–Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen–Positive Patients With Chronic Hepatitis B." Journal of Infectious Diseases 222, no. 4 (2020): 611–18. http://dx.doi.org/10.1093/infdis/jiaa136.

Full text

Abstract:

Abstract Background Safe nucleos(t)ide analogue discontinuation in chronic hepatitis B (CHB) is an unmet need. We aimed to investigate whether combining hepatitis B virus (HBV) RNA and hepatitis B core–related antigen (HBcrAg) could perform satisfactorily in predicting off-treatment outcomes. Methods The evaluation cohort included 127 hepatitis B e antigen (HBeAg)–positive patients from a multicenter prospective trial who stopped telbivudine-based therapy after achieving HBeAg seroconversion and HBV DNA &lt; 50 IU/mL for &gt; 48 weeks. As validation, 59 patients treated with entecavir

APA, Harvard, Vancouver, ISO, and other styles

29

Cramp, M. E., H. C. Grundy, R. M. Perinpanayagam, and D. E. Barnado. "Seroprevalence of Hepatitis B and C Virus in Two Institutions Caring for Mentally Handicapped Adults." Journal of the Royal Society of Medicine 89, no. 7 (1996): 401–2. http://dx.doi.org/10.1177/014107689608900712.

Full text

Abstract:

Hepatitis B virus infection is common in institutions caring for the mentally handicapped. Hepatitis B virus and hepatitis C virus share routes of transmission but the prevalence of hepatitis C virus infection in this population is unknown. We have tested 101 patients from two institutions in South-East England caring for adults with mental handicap for the presence of hepatitis C antibody, hepatitis B core antibody, and if necessary hepatitis B surface antigen. None tested positive for hepatitis C antibody, but 43 had hepatitis B core antibody of whom 14 were chronic carriers positive for hep

APA, Harvard, Vancouver, ISO, and other styles

30

Borojevic, Branko, Ayushi Chauhan, and Scott Patterson. "Liver failure from delayed hepatitis B reactivation in anti-HBc-positive patient following rituximab for B-cell lymphoma." BMJ Case Reports 14, no. 7 (2021): e243526. http://dx.doi.org/10.1136/bcr-2021-243526.

Full text

Abstract:

A 93-year-old man was admitted with 1 week of frank jaundice and abdominal pain. His medical history included diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, hydroxydaunomycin, oncovin and prednisolone (R-CHOP) chemotherapy 10 months prior. His investigations revealed marked hyperbilirubinemia with a total bilirubin of 355 μmol/L, along with a 17-fold elevation in alanine transaminase and impaired hepatic synthetic function. He tested hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (HBsAb) negative, hepatitis B core antibody (HBcAb) positive and

APA, Harvard, Vancouver, ISO, and other styles

31

Yang, Shu-Sheng, Fei Fu, Qian-Kun Xuan, et al. "Hepatitis B surface antigen-negative but hepatitis B envelope antigen-positive false occult hepatitis B virus infection: A case report." World Journal of Hepatology 16, no. 10 (2024): 1379–87. http://dx.doi.org/10.4254/wjh.v16.i10.1379.

Full text

Abstract:

BACKGROUND Occult hepatitis B infection (OBI) is characterized by the detection of hepatitis B virus (HBV) DNA in serum (usually HBV DNA < 200 IU/mL) or the liver but negativity for hepatitis B surface antigen (HBsAg). The diagnosis of OBI relies on the sensitivity of assays used in the detection of HBV DNA and HBsAg. HBsAg assays with inadequate sensitivity or inability to detect HBV S variants may lead to misdiagnosis of OBI in people with overt HBV infection. CASE SUMMARY We report a HBsAg-negative but hepatitis B envelope antigen-positive patient who had a significant HBV DNA level. The

APA, Harvard, Vancouver, ISO, and other styles

32

Yang, Shu-Sheng, Fei Fu, Qian-Kun Xuan, et al. "Hepatitis B surface antigen-negative but hepatitis B envelope antigen-positive false occult hepatitis B virus infection: A case report." World Journal of Hepatology 16, no. 10 (2024): 1199–207. http://dx.doi.org/10.4254/wjh.v16.i10.1199.

Full text

Abstract:

BACKGROUND Occult hepatitis B infection (OBI) is characterized by the detection of hepatitis B virus (HBV) DNA in serum (usually HBV DNA < 200 IU/mL) or the liver but negativity for hepatitis B surface antigen (HBsAg). The diagnosis of OBI relies on the sensitivity of assays used in the detection of HBV DNA and HBsAg. HBsAg assays with inadequate sensitivity or inability to detect HBV S variants may lead to misdiagnosis of OBI in people with overt HBV infection. CASE SUMMARY We report a HBsAg-negative but hepatitis B envelope antigen-positive patient who had a significant HBV DNA level. The

APA, Harvard, Vancouver, ISO, and other styles

33

Hanbali, Amr, Yasser Khaled, Hussein Ajrouche, Shan Ansari, and Nalini Janakiraman. "Incidence of Hepatitis B Reactivation in Association with Rituximab Therapy." Blood 108, no. 11 (2006): 2766. http://dx.doi.org/10.1182/blood.v108.11.2766.2766.

Full text

Abstract:

Abstract Introduction: Hepatitis B reactivation and fulminant acute hepatitis has been described in association with Rituximab therapy. However, the incidence of these adverse effects is unknown and there are no established guidelines for hepatitis B screening prior to Rituximab therapy. Method: To study the incidence of hepatitis B reactivation in association with Rituximab, we reviewed the records of 456 patients treated with Rituximab between 1998 and 2004. We identified 32 patients with positive hepatitis B serology who received Rituximab alone (#14) or with chemotherapy (#18) for NHL (n#1

APA, Harvard, Vancouver, ISO, and other styles

34

ter Borg, Martijn J., та Harry L. A. Janssen. "Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B". Annals of Internal Medicine 143, № 5 (2005): 391. http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Chan, Henry L. Y., та Joseph J. Y. Sung. "Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B". Annals of Internal Medicine 143, № 5 (2005): 391. http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Uemoto, S., Y. Inomata, A. Sannomiya, et al. "Posttransplant Hepatitis B Infection in Liver Transplantation With Hepatitis B Core Antibody-Positive Donors." Transplantation Proceedings 30, no. 1 (1998): 134–35. http://dx.doi.org/10.1016/s0041-1345(97)01211-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Marcellin, Patrick, Ting-Tsung Chang, Seng Gee Lim, et al. "Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B." New England Journal of Medicine 348, no. 9 (2003): 808–16. http://dx.doi.org/10.1056/nejmoa020681.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Bonino, Ferruccio, and Maurizia Rossana Brunetto. "Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview." Journal of Hepatology 39 (January 2003): 160–63. http://dx.doi.org/10.1016/s0168-8278(03)00319-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Cooksley, Graham. "The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon." Journal of Hepatology 39 (January 2003): 143–45. http://dx.doi.org/10.1016/s0168-8278(03)00327-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Lao, Terence T., K. L. Cheung, and Vincent Wong. "Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women." Vaccine 33, no. 1 (2015): 15–16. http://dx.doi.org/10.1016/j.vaccine.2014.05.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Ko, Stephen C., Sarah F. Schillie, Tanja Walker, et al. "Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women." Vaccine 32, no. 18 (2014): 2127–33. http://dx.doi.org/10.1016/j.vaccine.2014.01.099.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tur-Kaspa, R., M. Braun, and Z. Ben-Ari. "HEPATITIS B CORE ANTIBODY-POSITIVE LIVER RECIPIENTS AND HEPATITIS B REACTIVATION AFTER LIVER TRANSPLANTATION." Transplantation 73, no. 3 (2002): 331–32. http://dx.doi.org/10.1097/00007890-200202150-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Phinius, Bonolo B., Motswedi Anderson, Margaret Mokomane, et al. "Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana." Viruses 15, no. 7 (2023): 1544. http://dx.doi.org/10.3390/v15071544.

Full text

Abstract:

(1) Background: Hepatitis B core antibodies (anti-HBc) are a marker of hepatitis B virus (HBV) exposure; hence, a normal HBV serology profile is characterized by HBV surface antigen (HBsAg) and anti-HBc positivity. However, atypical HBV serologies occur, and we aimed to determine the prevalence of an atypical profile (HBsAg+/anti-HBc-) in a cohort of people with HIV-1 (PWH) in Botswana. (2) Methods: Plasma samples from an HIV-1 cohort in Botswana (2013–2018) were used. The samples were screened for HBsAg and anti-HBc. Next-generation sequencing was performed using the GridION platform. The Wil

APA, Harvard, Vancouver, ISO, and other styles

44

Tassopoulos, Nicolaos C., Riccardo Volpes, Giuseppe Pastore, et al. "Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis BB." Hepatology 29, no. 3 (1999): 889–96. http://dx.doi.org/10.1002/hep.510290321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Janzen, L., G. Y. Minuk, M. Fast, and K. N. Bernstein. "Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data." Journal of the American Society of Nephrology 7, no. 8 (1996): 1228–34. http://dx.doi.org/10.1681/asn.v781228.

Full text

Abstract:

This report describes hepatitis B vaccinations that resulted in transient hepatitis B surface antigen positivity in six adult hemodialysis patients. Initially, three patients were incidentally discovered to be hepatitis B surface antigen-positive temporally related to hepatitis B vaccination. Two other patients who displayed transient positivity were among 15 hemodialysis patients under prospective surveillance after receiving a dose of hepatitis B vaccine. The sixth patient was negative for hepatitis B surface antigen when monitored in the prospective surveillance group but was incidentally f

APA, Harvard, Vancouver, ISO, and other styles

46

Aghayeva, S. Сh, and A. A. Hidayatov. "THE IMPACT OF OCCULT HEPATITIS B INFECTION ON THE COURSE OF CHRONIC HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 22, no. 1 (2022): 4–8. http://dx.doi.org/10.31718/2077-1096.22.1.4.

Full text

Abstract:

The prevalence of viral hepatitis B and C in Azerbaijan is 3.2% and 4.3% respectively. The incidence of occult hepatitis B has not been previously studied. The purpose of this study is to assess the prevalence of occult hepatitis B infection among patients with chronic hepatitis C, as well as to assess the impact of occult hepatitis B on the progression of liver disease and to identify the likelihood of viral/clinical reactivation of occult hepatitis B during treatment with direct-acting antiviral drugs. Results. The study included 164 patients with chronic hepatitis C with the absence of over

APA, Harvard, Vancouver, ISO, and other styles

47

Chonco, F. M., and S. Rangiah. "Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa." South African Family Practice 61, no. 2 (2019): 51. http://dx.doi.org/10.4102/safp.v61i2.5004.

Full text

Abstract:

Background: HIV/HBV co-infection remains a global threat to HIV management despite the available effective hepatitis B vaccine and hepatitis B covering antiretroviral therapy. Many studies done in South Africa and internationally showed high prevalence of HIV/hepatitis B co-infection, which mandated routine screening for both infections before initiating HAART. Fewer studies have highlighted the prevalence of hepatitis B susceptibility in the general population starting HAART and most of them were limited to children and high-risk groups. The aim of this study was to demonstrate the extent of

APA, Harvard, Vancouver, ISO, and other styles

48

Sonneveld, Milan J., Bettina E. Hansen, Teerha Piratvisuth, et al. "Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels." Hepatology 58, no. 3 (2013): 872–80. http://dx.doi.org/10.1002/hep.26436.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Ocan, Moses, Frances Acheng, Carol Otike, Judith Beinomugisha, David Katete, and Celestino Obua. "Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda." PLOS ONE 17, no. 1 (2022): e0262126. http://dx.doi.org/10.1371/journal.pone.0262126.

Full text

Abstract:

Hepatitis B vaccine has contributed to the reduction in hepatitis B virus infections and chronic disease globally. Screening to establish extent of vaccine induced immune response and provision of booster dose are limited in most low-and-middle income countries (LMICs). Our study investigated the extent of protective immune response and breakthrough hepatitis B virus infections among adult vaccinated healthcare workers in selected health facilities in northern Uganda. A cross-sectional study was conducted among 300 randomly selected adult hepatitis B vaccinated healthcare workers in Lira and G

APA, Harvard, Vancouver, ISO, and other styles

50

Mas, Antoni, María Buti, Rafael Esteban, et al. "Hepatitis B virus and hepatitis D virus replication in HBsAg-positive fulminant hepatitis." Hepatology 11, no. 6 (1990): 1062–65. http://dx.doi.org/10.1002/hep.1840110624.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!